ClinResearch, GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Cologne Germany (1999)
Status: Acquired by Aptiv Solutions (2014) → now ICON (2014)

Organization Overview

First Clinical Trial
2007
NCT00777348
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (3)

cromoglicic acid (Intal) (1 trial)

formoterol (foradil) (1 trial)

reproterol (1 trial)

Drugs in Phase 1 Trials (2)

azelastine (astelin) (2 trials)

fluticasone (cutivate) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Asthma, Exercise-Induced (Phase 2)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 5